Bioprocess Monitoring Market To Reach $6.29 Billion By 2030

Bioprocess Monitoring Market Growth & Trends

The global bioprocess monitoring market is anticipated to reach USD 6.29 billion by 2030 and is projected to grow at a CAGR of 9.45% from 2024 to 2030, according to a new report by Grand View Research, Inc. Several factors are driving the market growth. More accurate and trustworthy bioprocess monitoring instruments are required as the market for cutting-edge and effective biopharmaceutical products-such as vaccines, recombinant proteins, and monoclonal antibodies-continues to grow. These goods are essential for improving public health and treating a range of medical issues. Moreover, it is anticipated that the growing number of alliances and collaborations among industry participants will support market expansion. For instance, Beckman Coulter Life Sciences and Flownamics established a strategic alliance in August 2022 to create a cutting-edge, automated solution for the real-time monitoring and management of bioprocess cultures. This collaboration combines Vi-CELL BLU Cell Viability Analyzer with Flownamics' Seg-Flow S3 Automated On-Line, aiming to enhance the efficiency and accuracy of bioprocess monitoring.

There are several reasons for the market expansion for bioprocess monitoring, Still, one of the main ones is the notable rise in capital expenditures made by pharmaceutical companies for the creation and manufacturing of biologics. The ability of biologics to treat a wide range of illnesses and enhance public health has made them more well-known in recent years. For instance, in January 2024, the multinational biopharmaceutical giant AbbVie invested USD 223 million in its Singapore manufacturing location to improve its biologics manufacturing capabilities. Pharmaceutical companies are making significant investments in R&D, manufacturing capacity, and regulatory compliance to bring these biologics to market as they work to create novel treatments.

In addition, government programs and financial support for biotechnology research have been crucial in promoting creativity and expansion in the bioprocess monitoring industry. The creation of cutting-edge technologies and their commercialization are the results of partnerships between government, business, and academia.

The biotechnology industry's boom in research and development (R&D) has greatly contributed to the market expansion for bioprocess monitoring. The development of cutting-edge tools and methods brought about by this surge in investment and creativity has completely changed how bioprocesses are observed and managed. The market for bioprocess monitoring is now growing quickly because of the sophisticated instruments and techniques that make it possible to measure several parameters precisely and efficiently while biological products are being produced.

 Request a free sample copy or view report summary: Bioprocess Monitoring Market Report

Bioprocess Monitoring Market Report Highlights

• Based on product, the reagents & kits segment led the market with the largest revenue share of 70.31% share in 2023, due to the high demand for personalized medicines. On the other hand, the software segment is expected to grow at the fastest CAGR during the forecast period

• Based on application, the host cell residual DNA/protein quantitation segment held the market with the largest revenue share of 30.88% in 2023. On the other hand, the mycoplasma detection segment is expected to grow at the fastest CAGR during the forecast period

• Based on end-use, the pharmaceutical & biotechnology companies led the market with the largest revenue share of 46.90% in 2023, and CMOs & CROs segment is expected to grow at a significant CAGR during the forecast period

• North America dominated the market with the revenue share of 43.24% in 2023, driven by rising demand for advanced technology, increasing regulatory compliance, and a focus on improving product quality

• Asia Pacific is expected to grow at the fastest CAGR over the forecast period, this upsurge is attributed to the growing biotechnology & pharmaceutical sectors within the region, propelled by factors such as heightened healthcare spending and the expansion of research & development activities

Bioprocess Monitoring Market Segmentation

Grand View Research has segmented the global bioprocess monitoring market report based on product, application, end use, and region:

Bioprocess Monitoring Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Kits

• Instruments

• Software

Bioprocess Monitoring Application Outlook (Revenue, USD Million, 2018 - 2030)

• Host Cell Residual DNA/Protein Quantitation

• Mycoplasma Detection

• Viral Titer Determination

• Adventitious Virus Testing

• Other Applications

Bioprocess Monitoring End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• CROs & CMOs

• Academic & Research Institutes

Bioprocess Monitoring Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Bioprocess Monitoring Market

• Thermo Fisher Scientific Inc.

• QIAGEN

• Merck KGaA

• F. Hoffmann-La Roche Ltd

• Bio-Rad Laboratories, Inc.

• Bio-Techne

• Enzo Life Sciences, Inc.,

• Maravai LifeSciences.

• Lonza

• Applied Biological Materials Inc.